Holen Sie sich die Stockscreener-App
18.50
0.24%
0.045
Handel nachbörslich:
18.51
0.005
+0.03%
Schlusskurs vom Vortag:
$18.46
Offen:
$18.4
24-Stunden-Volumen:
36,273
Relative Volume:
0.69
Marktkapitalisierung:
$1.30B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.81%
1M Leistung:
-19.93%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$17.65
$18.62
1-Wochen-Bereich:
$17.00
$19.49
52-Wochen-Spanne:
$12.51
$25.00
Yd Bio Ltd Stock (YDES) Company Profile
Vergleichen Sie YDES mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
YDES
Yd Bio Ltd
|
18.50 | 1.23B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Yd Bio Ltd Aktie (YDES) Neueste Nachrichten
Metals & Mining Virtual Investor Conference: Presentations Now Available for Online Viewing - The Manila Times
CAP Accreditation Secured: YD Bio partner EG BioMed's CLIA lab in Bothell bolsters U.S. cancer testing capabilities - Stock Titan
YD Bio Limited Reports Unaudited Half Year 2025 Financial Results - BioSpace
MARTEN TRANSPORT CLOSES ON THE SALE OF ASSETS RELATED TO INTERMODAL BUSINESS - The Manila Times
Hub Group Closes on the Acquisition of Marten Transport Intermodal - The Manila Times
Three Small-Caps Took Off On News And Fresh Deals - Finimize
YD Bio announces COO resignation and updates on public warrant registration By Investing.com - Investing.com Nigeria
YD Bio announces COO resignation and updates on public warrant registration - Investing.com
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Concentrix Posts Downbeat Earnings, Joins Legacy Education, Kingsoft Cloud And Other Big Stocks Moving Lower In Friday's Pre-Market SessionApellis Pharmaceuticals (NASDAQ:APLS), Concentrix (NASDAQ:CNXC) - Benzinga
Freeport-McMoRan, Harmony Biosciences, Cohu, And Other Big Stocks Moving Lower On Wednesday - Benzinga
Xinhua Finance: Chongqing’s Intelligent Bionic Robot Competition Highlights Advances in “Evolving” Robotics - digitalmore.co
New Mountain Finance, Texas Instruments, Analog… - inkl
Why Check-Cap Shares Are Trading Higher By 183%; Here Are 20 Stocks Moving Premarket - Benzinga
New Mountain Finance, Texas Instruments, Analog Devices And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
We're Keeping An Eye On YD Bio's (NASDAQ:YDES) Cash Burn Rate - 富途牛牛
Why Oxford Industries Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - inkl
Breeze Holdings Acquisition (YDES) Rises 31% Over the Past Month - simplywall.st
Why Did YD Bio Plunge 14.37% Despite Revenue Growth? - AInvest
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday - Benzinga
YD Bio Limited shares rise 7.33% premarket after being added to NASDAQ. - AInvest
Yd Bio Limited shares rise 56.25% intraday after being added to NASDAQ. - AInvest
YD Bio Stock Fuels Retail-Trader Excitement After Nasdaq Listing Through Breeze SPAC Deal - Asianet Newsable
YD Bio Limited Announces Closing of Business Combination - citybiz
YDES Stock Price and Chart — NASDAQ:YDES - TradingView
YDESBreeze Holdings Latest Stock News & Market Updates - Stock Titan
YD Bio's Nasdaq Debut: A Strategic SPAC Merger Positions the Biotech Innovator for High-Growth Catalysts - AInvest
Nasdaq: YD Bio Completes Merger With Breeze - AInvest
YD Bio Shares to Begin Trading on Nasdaq After Completing Merger With Breeze - MarketScreener
YD Bio Limited begins trading on Nasdaq under YDES, YDESW symbols. - AInvest
YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market - PR Newswire
Cancer Detection Biotech YD Bio Debuts on Nasdaq: DNA Methylation Pioneer Raises $11.5M for Expansion - Stock Titan
Cancer Detection Biotech YD Bio Goes Public: $11.5M SPAC Deal Powers DNA Methylation Technology - Stock Titan
Taiwan Biotech YD Biopharma Secures Path to Nasdaq Through Breeze Holdings SPAC Merger Approval - Stock Titan
Reintegration of blastema and stump by reciprocal interaction for functional joint regeneration in frogs - ScienceDirect.com
Biocon Biologics and Yoshindo expand access to Ustekinumab Biosimilar in Japan - BioSpectrum Asia
Ventral-to-dorsal electrocyte development in electric organs of electric eel (Electrophorus) - ScienceDirect.com
Reproductive adaptation of Astyanax mexicanus under nutrient limitation - ScienceDirect.com
Avian bioresources for developmental biology: Chicken and quail resources in the United Kingdom, France, and Japan - ScienceDirect.com
Breeze Holdings Acquisition To Merge with YD Biopharma - citybiz
MARKET DATA - The Wall Street Journal
US Share Prices - London South East
From neural tube to spinal cord: The dynamic journey of the dorsal neuroepithelium - ScienceDirect.com
Boron homeostasis affects Longan yield: a study of NIP and BOR boron transporter of two cultivars - BMC Plant Biology
Cardiac competence of the paraxial head mesoderm fades concomitant with a shift towards the head skeletal muscle programme - ScienceDirect.com
The heparan sulfate modification enzyme, Hs6st1, governs Xenopus neuroectodermal patterning by regulating distributions of Fgf and Noggin - ScienceDirect.com
Mechanism underlying retinoic acid-dependent metamorphosis in the starfish - ScienceDirect.com
Site pleiotropy of a stickleback Bmp6 enhancer - ScienceDirect.com
Polarity proteins: Shaping dendritic spines and memory - ScienceDirect.com
Reflections on the past, present and future of developmental biology - ScienceDirect.com
Finanzdaten der Yd Bio Ltd-Aktie (YDES)
Es liegen keine Finanzdaten für Yd Bio Ltd (YDES) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):